Skip to main content
Fig. 1 | Journal of Medical Case Reports

Fig. 1

From: Symptomatic methemoglobinemia in a patient with metastatic clear cell renal cell carcinoma treated with pembrolizumab and axitinib combination therapy: a case report

Fig. 1

Axial contrast enhanced computed tomography scan of the abdomen and pelvis. Interval decreases in size of liver metastases with reference measurements are as follows: T11: 1.6 × 1.9 cm metastasis of liver towards the dome compared to baseline of 3.7 × 3.4 cm. T12: 1.6 × 2.2 cm metastasis towards the dome more centrally compared to baseline of 3.3 × 3.5 cm. L1: 2.1 × 2.1 cm metastasis inferior right hepatic lobe compared to baseline of 3.2 × 3.9 cm

Back to article page